A new study published in JAMA Network Open reports that insulin levels rise first, and then people develop obesity - not the other way around.
Why is this important? Traditional teaching is that obesity is related to dangerous health outcomes, including premature death.
However, as the study's authors point out, the association between obesity and premature death is not strong and fails many criteria to suggest a cause and effect relationship. Perhaps the risks linked to obesity have more to do with poor underlying metabolic health than obesity itself.
Additionally, traditional medical belief is that people become obese first, which then triggers insulin resistance and hyperinsulinemia. If that is the case, any weight loss technique, including liposuction, should be equally beneficial for improving insulin sensitivity.
But if the opposite is true - if insulin resistance does lead to obesity - then only weight loss strategies that also lower insulin resistance and improve metabolic health will successfully address the underlying metabolic dysfunction and reduce the risk of future health complications.
While the current study does not prove that insulin resistance causes obesity, it makes a strong case for it.
The authors reviewed 60 studies - randomized trials and observational studies - with over 5,600 participants. They concluded that subjects had elevated insulin levels before they had a rise in their BMI. But the converse was not true. They did not start with elevated BMI and develop elevated insulin levels later.
Considering the number of people with metabolic dysfunction who are not overweight and the number of people with obesity who don't have metabolic dysfunction, the paradigm of insulin driving obesity makes sense.
The so-called TOFI (thin on the outside, "fat" on the inside) or "skinny-fat" population tends to have visceral fat (fat around the organs) and insulin resistance, but they don't have the traditional amount of fat to be considered obese.
Consider the patient with type 2 diabetes or polycystic ovary syndrome (PCOS). They are often overweight, and their diagnosis gets "blamed" on their excess weight. But, perhaps it has more to do with rising insulin levels than the weight itself.
If the disease state is more related to elevated insulin levels, then preventive measures and treatment strategies should focus more on addressing insulin resistance and metabolic health - and focus less on the number on the scale.
It's true that many different weight loss strategies can help lower insulin levels and improve metabolic health - but not all.
Low-carb diets that focus on reducing carbohydrates, getting adequate protein, and adding fat for flavor have demonstrated significant benefits for weight loss, reducing insulin resistance, and improving blood sugar control. Low-carb diets aren't the only approach, but they certainly are an effective one.
If you are interested in getting started on a low-carb diet, try starting with our two-week Get Started Keto Challenge or our 10-week Weight Loss for Good course. You can also experiment with our personalized meal planner to find which of our 1,000+ premium recipes will fit your health goals.
Thanks for reading,
Bret Scher, MD FACC
Start your FREE 30-day trial!
Get delicious recipes, amazing meal plans, video courses, health guides, and weight loss advice from doctors, dietitians, and other experts.
